Anti-bribery and corruption in the sector
Nigel Layton, our Global Head of Pharma & Life Sciences and UK Head of Investigations, gives his insight on anti-bribery and corruption within the pharma and life sciences sector.
Thanks for visiting Mazars at the FT Live: Global Pharma & Biotech Summit. It was great to meet you and we hope you enjoyed your special ‘Mazars edition’ Tony’s Chocolonely bar.
At Mazars, we are committed to supporting the pharma and life sciences sector – helping companies navigate disruption, embrace innovation and grow with confidence. You can browse a selection of our latest sector insights and expert analysis by our dedicated team here.
For more information or to sign up for the latest pharma & life sciences news and insights, please get in touch.
Private equity and deals activity in the sector
05/10/2023. Tarifa Simpson, our Healthcare & Life Sciences Co-Lead and Due Diligence Partner, gives her views on the current deals environment within the healthcare and life sciences sector.
Conducting an effective internal investigation
As companies face increasing scrutiny and an aggressive drive to criminalise corporate misconduct, there has been a marked increase in firms conducting internal investigations. Nigel Layton, our Head of Investigations and Global Head of Pharma & Life Sciences, explains the key components of a successful internal investigation.
Bringing the ‘E’ and the ’S’ together
Acting on the principles embodied in ESG (environmental, social and governance) is fraught with difficulty.
Apprenticeship Levy FAQs
06/02/23. Employing apprentices is nothing new. It has been in place for hundreds of years, in various forms. However, one of the biggest changes in a generation took place in April 2017 as the Apprenticeship Levy was introduced to give employers more control over how they govern and control training costs.
Pay and reward during a cost-of-living crisis
The cost of living and energy crisis as well as a continued potential discontent continues to loom large. Despite recent Government measures.
Pharma & life sciences
Specialist experience and industry expertise to help you navigate disruption, embrace innovation and grow with confidence.
Global Pharma & Life Sciences team
With specialist pharma and life sciences hubs in the UK, USA, Switzerland, France, Germany and Ireland, our dedicated Global Pharma & Life Sciences team combines global experience and industry expertise.
Pharma & life sciences insights
Explore all our expert analysis and insights for the pharma and life sciences sector.
National contacts
Nigel Layton Partner - Head of Pharma & Life Sciences London
